CN101007114A - 一种肿瘤患者辅助用药品或保健品及其制备方法 - Google Patents
一种肿瘤患者辅助用药品或保健品及其制备方法 Download PDFInfo
- Publication number
- CN101007114A CN101007114A CNA2007100367415A CN200710036741A CN101007114A CN 101007114 A CN101007114 A CN 101007114A CN A2007100367415 A CNA2007100367415 A CN A2007100367415A CN 200710036741 A CN200710036741 A CN 200710036741A CN 101007114 A CN101007114 A CN 101007114A
- Authority
- CN
- China
- Prior art keywords
- adjuvant drug
- health product
- drug product
- parts
- carapax
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 238000002360 preparation method Methods 0.000 title claims abstract description 19
- 206010028980 Neoplasm Diseases 0.000 title claims abstract description 15
- 239000002671 adjuvant Substances 0.000 title claims description 29
- 239000003814 drug Substances 0.000 title abstract description 21
- 229940079593 drug Drugs 0.000 title description 6
- 235000013402 health food Nutrition 0.000 title 1
- 230000036541 health Effects 0.000 claims abstract description 29
- 239000000203 mixture Substances 0.000 claims abstract description 4
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims description 36
- 229940126534 drug product Drugs 0.000 claims description 27
- 239000000825 pharmaceutical preparation Substances 0.000 claims description 27
- 239000000047 product Substances 0.000 claims description 27
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 20
- 239000009636 Huang Qi Substances 0.000 claims description 13
- 239000000706 filtrate Substances 0.000 claims description 12
- 239000008187 granular material Substances 0.000 claims description 9
- 235000019640 taste Nutrition 0.000 claims description 9
- 239000002994 raw material Substances 0.000 claims description 8
- 239000012530 fluid Substances 0.000 claims description 6
- 238000002156 mixing Methods 0.000 claims description 6
- 238000004064 recycling Methods 0.000 claims description 6
- 238000003756 stirring Methods 0.000 claims description 6
- 239000004375 Dextrin Substances 0.000 claims description 5
- 229920001353 Dextrin Polymers 0.000 claims description 5
- 235000019425 dextrin Nutrition 0.000 claims description 5
- 238000001035 drying Methods 0.000 claims description 5
- 239000007788 liquid Substances 0.000 claims description 5
- 239000002552 dosage form Substances 0.000 claims description 4
- 241000545442 Radix Species 0.000 claims description 3
- 239000002775 capsule Substances 0.000 claims description 3
- 239000003826 tablet Substances 0.000 claims description 2
- 238000000034 method Methods 0.000 abstract description 6
- 230000036737 immune function Effects 0.000 abstract description 3
- 230000002195 synergetic effect Effects 0.000 abstract description 3
- 230000008569 process Effects 0.000 abstract description 2
- 241000270708 Testudinidae Species 0.000 abstract 1
- 229940107666 astragalus root Drugs 0.000 abstract 1
- 235000013399 edible fruits Nutrition 0.000 abstract 1
- 238000000605 extraction Methods 0.000 abstract 1
- 210000003296 saliva Anatomy 0.000 abstract 1
- 239000008280 blood Substances 0.000 description 19
- 210000004369 blood Anatomy 0.000 description 18
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 18
- 230000000694 effects Effects 0.000 description 17
- 238000011282 treatment Methods 0.000 description 14
- 201000010099 disease Diseases 0.000 description 13
- 210000001015 abdomen Anatomy 0.000 description 10
- 238000012360 testing method Methods 0.000 description 10
- 241001465754 Metazoa Species 0.000 description 9
- 230000007812 deficiency Effects 0.000 description 9
- 210000003734 kidney Anatomy 0.000 description 9
- 241000699670 Mus sp. Species 0.000 description 8
- 210000000952 spleen Anatomy 0.000 description 8
- 208000024891 symptom Diseases 0.000 description 8
- 238000002512 chemotherapy Methods 0.000 description 7
- 230000037396 body weight Effects 0.000 description 6
- 241000411851 herbal medicine Species 0.000 description 6
- 208000031648 Body Weight Changes Diseases 0.000 description 5
- 208000005718 Stomach Neoplasms Diseases 0.000 description 5
- 230000004579 body weight change Effects 0.000 description 5
- 206010061428 decreased appetite Diseases 0.000 description 5
- 208000002173 dizziness Diseases 0.000 description 5
- 230000006870 function Effects 0.000 description 5
- 206010017758 gastric cancer Diseases 0.000 description 5
- 210000004185 liver Anatomy 0.000 description 5
- 201000011549 stomach cancer Diseases 0.000 description 5
- 206010003549 asthenia Diseases 0.000 description 4
- 208000035475 disorder Diseases 0.000 description 4
- 238000002474 experimental method Methods 0.000 description 4
- 235000013305 food Nutrition 0.000 description 4
- 230000002980 postoperative effect Effects 0.000 description 4
- 238000001959 radiotherapy Methods 0.000 description 4
- 210000002784 stomach Anatomy 0.000 description 4
- 238000005728 strengthening Methods 0.000 description 4
- 238000002560 therapeutic procedure Methods 0.000 description 4
- 231100000331 toxic Toxicity 0.000 description 4
- 230000002588 toxic effect Effects 0.000 description 4
- 206010000077 Abdominal mass Diseases 0.000 description 3
- CMSMOCZEIVJLDB-UHFFFAOYSA-N Cyclophosphamide Chemical compound ClCCN(CCCl)P1(=O)NCCCO1 CMSMOCZEIVJLDB-UHFFFAOYSA-N 0.000 description 3
- 230000008901 benefit Effects 0.000 description 3
- 230000017531 blood circulation Effects 0.000 description 3
- 201000011510 cancer Diseases 0.000 description 3
- 210000000038 chest Anatomy 0.000 description 3
- 229960004397 cyclophosphamide Drugs 0.000 description 3
- 230000006378 damage Effects 0.000 description 3
- 206010016256 fatigue Diseases 0.000 description 3
- 239000000463 material Substances 0.000 description 3
- 210000000214 mouth Anatomy 0.000 description 3
- 230000001737 promoting effect Effects 0.000 description 3
- 206010024264 Lethargy Diseases 0.000 description 2
- 241000699666 Mus <mouse, genus> Species 0.000 description 2
- 230000002159 abnormal effect Effects 0.000 description 2
- 230000000259 anti-tumor effect Effects 0.000 description 2
- 210000000988 bone and bone Anatomy 0.000 description 2
- 210000004027 cell Anatomy 0.000 description 2
- 230000008859 change Effects 0.000 description 2
- 238000006243 chemical reaction Methods 0.000 description 2
- 235000009508 confectionery Nutrition 0.000 description 2
- 239000012153 distilled water Substances 0.000 description 2
- 230000003203 everyday effect Effects 0.000 description 2
- 210000003414 extremity Anatomy 0.000 description 2
- 238000001990 intravenous administration Methods 0.000 description 2
- 210000000265 leukocyte Anatomy 0.000 description 2
- 238000004519 manufacturing process Methods 0.000 description 2
- 230000005855 radiation Effects 0.000 description 2
- 238000011160 research Methods 0.000 description 2
- 239000002689 soil Substances 0.000 description 2
- 230000001225 therapeutic effect Effects 0.000 description 2
- 208000019901 Anxiety disease Diseases 0.000 description 1
- 208000028399 Critical Illness Diseases 0.000 description 1
- 206010016807 Fluid retention Diseases 0.000 description 1
- GHASVSINZRGABV-UHFFFAOYSA-N Fluorouracil Chemical compound FC1=CNC(=O)NC1=O GHASVSINZRGABV-UHFFFAOYSA-N 0.000 description 1
- 241000222336 Ganoderma Species 0.000 description 1
- 208000032843 Hemorrhage Diseases 0.000 description 1
- 206010062717 Increased upper airway secretion Diseases 0.000 description 1
- 238000012449 Kunming mouse Methods 0.000 description 1
- 206010027514 Metrorrhagia Diseases 0.000 description 1
- NRGONRDRXCPMIC-GDKBPFBDSA-N N1C=2C(=O)NC(N)=NC=2NCC1CNC1=CC=C(C(=O)N[C@@H](CC(C=O)C(O)=O)C(O)=O)C=C1 Chemical compound N1C=2C(=O)NC(N)=NC=2NCC1CNC1=CC=C(C(=O)N[C@@H](CC(C=O)C(O)=O)C(O)=O)C=C1 NRGONRDRXCPMIC-GDKBPFBDSA-N 0.000 description 1
- 206010030113 Oedema Diseases 0.000 description 1
- 240000007594 Oryza sativa Species 0.000 description 1
- 235000007164 Oryza sativa Nutrition 0.000 description 1
- 206010040007 Sense of oppression Diseases 0.000 description 1
- 206010070834 Sensitisation Diseases 0.000 description 1
- 208000032023 Signs and Symptoms Diseases 0.000 description 1
- CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 description 1
- 229930006000 Sucrose Natural products 0.000 description 1
- 210000000662 T-lymphocyte subset Anatomy 0.000 description 1
- 206010048245 Yellow skin Diseases 0.000 description 1
- 230000001133 acceleration Effects 0.000 description 1
- 238000009098 adjuvant therapy Methods 0.000 description 1
- 208000022531 anorexia Diseases 0.000 description 1
- 230000001093 anti-cancer Effects 0.000 description 1
- 230000036506 anxiety Effects 0.000 description 1
- 235000019789 appetite Nutrition 0.000 description 1
- 230000036528 appetite Effects 0.000 description 1
- 238000013459 approach Methods 0.000 description 1
- 210000001367 artery Anatomy 0.000 description 1
- 230000003542 behavioural effect Effects 0.000 description 1
- 230000000740 bleeding effect Effects 0.000 description 1
- 238000009534 blood test Methods 0.000 description 1
- 210000000481 breast Anatomy 0.000 description 1
- VSJKWCGYPAHWDS-FQEVSTJZSA-N camptothecin Chemical compound C1=CC=C2C=C(CN3C4=CC5=C(C3=O)COC(=O)[C@]5(O)CC)C4=NC2=C1 VSJKWCGYPAHWDS-FQEVSTJZSA-N 0.000 description 1
- 238000009104 chemotherapy regimen Methods 0.000 description 1
- 235000015111 chews Nutrition 0.000 description 1
- 230000004087 circulation Effects 0.000 description 1
- 238000009096 combination chemotherapy Methods 0.000 description 1
- 150000001875 compounds Chemical class 0.000 description 1
- 239000000470 constituent Substances 0.000 description 1
- 230000003247 decreasing effect Effects 0.000 description 1
- 230000013872 defecation Effects 0.000 description 1
- 230000002950 deficient Effects 0.000 description 1
- 230000000994 depressogenic effect Effects 0.000 description 1
- 238000013461 design Methods 0.000 description 1
- 235000005911 diet Nutrition 0.000 description 1
- 230000037213 diet Effects 0.000 description 1
- 230000004069 differentiation Effects 0.000 description 1
- 238000009792 diffusion process Methods 0.000 description 1
- 239000006185 dispersion Substances 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 230000002349 favourable effect Effects 0.000 description 1
- 229960002949 fluorouracil Drugs 0.000 description 1
- 230000009246 food effect Effects 0.000 description 1
- 235000021471 food effect Nutrition 0.000 description 1
- 238000009472 formulation Methods 0.000 description 1
- 239000007952 growth promoter Substances 0.000 description 1
- 210000002216 heart Anatomy 0.000 description 1
- 230000036039 immunity Effects 0.000 description 1
- 238000002649 immunization Methods 0.000 description 1
- 230000003053 immunization Effects 0.000 description 1
- 230000001976 improved effect Effects 0.000 description 1
- 230000006872 improvement Effects 0.000 description 1
- 230000002401 inhibitory effect Effects 0.000 description 1
- 238000007689 inspection Methods 0.000 description 1
- 230000010354 integration Effects 0.000 description 1
- 230000003907 kidney function Effects 0.000 description 1
- 210000003127 knee Anatomy 0.000 description 1
- 230000003908 liver function Effects 0.000 description 1
- 238000011068 loading method Methods 0.000 description 1
- 230000007774 longterm Effects 0.000 description 1
- 210000004072 lung Anatomy 0.000 description 1
- 210000004698 lymphocyte Anatomy 0.000 description 1
- 206010025482 malaise Diseases 0.000 description 1
- 201000004792 malaria Diseases 0.000 description 1
- 210000003205 muscle Anatomy 0.000 description 1
- 230000000474 nursing effect Effects 0.000 description 1
- 235000016709 nutrition Nutrition 0.000 description 1
- 230000035764 nutrition Effects 0.000 description 1
- 230000008506 pathogenesis Effects 0.000 description 1
- 230000001717 pathogenic effect Effects 0.000 description 1
- 230000001575 pathological effect Effects 0.000 description 1
- 230000007170 pathology Effects 0.000 description 1
- 230000002093 peripheral effect Effects 0.000 description 1
- 230000000144 pharmacologic effect Effects 0.000 description 1
- 208000026435 phlegm Diseases 0.000 description 1
- 235000021395 porridge Nutrition 0.000 description 1
- 239000000843 powder Substances 0.000 description 1
- 238000011084 recovery Methods 0.000 description 1
- 230000003014 reinforcing effect Effects 0.000 description 1
- 230000029058 respiratory gaseous exchange Effects 0.000 description 1
- 235000009566 rice Nutrition 0.000 description 1
- 238000011076 safety test Methods 0.000 description 1
- 230000028327 secretion Effects 0.000 description 1
- 230000008313 sensitization Effects 0.000 description 1
- 230000001954 sterilising effect Effects 0.000 description 1
- 238000004659 sterilization and disinfection Methods 0.000 description 1
- 239000005720 sucrose Substances 0.000 description 1
- 230000008093 supporting effect Effects 0.000 description 1
- 230000004083 survival effect Effects 0.000 description 1
- 231100000419 toxicity Toxicity 0.000 description 1
- 230000001988 toxicity Effects 0.000 description 1
- 210000004881 tumor cell Anatomy 0.000 description 1
- 238000002562 urinalysis Methods 0.000 description 1
- 210000003462 vein Anatomy 0.000 description 1
- 210000001835 viscera Anatomy 0.000 description 1
- 238000005303 weighing Methods 0.000 description 1
Landscapes
- Medicines Containing Plant Substances (AREA)
Abstract
Description
组别 | 剂量 | 动物数 | 观察期间动物死亡数 | 死亡率 | ||||||||||||
(g/kg) | (只) | 1 | 2 | 3 | 4 | 5 | 6 | 7 | 8 | 9 | 10 | 11 | 12 | 13 | (%) | |
雌性组雄性组 | 3232 | 2020 | 00 | 00 | 00 | 00 | 00 | 00 | 00 | 00 | 00 | 00 | 00 | 00 | 00 | 00 |
组别 | 性别 | 数量 | 第1天 | 第3天 | 第7天 | 第9天 | 第13天 |
试验组 | 雄雌 | 1010 | 18.91±0.7919.62±0.72 | 22.84±1.0921.66±1.19 | 24.09±1.4724.92±1.46 | 25.52±2.3625.12±1.15 | 29.42±1.9126.14±1.76 |
对照组 | 雄雌 | 1010 | 18.32±0.5319.28±0.79 | 20.02 ±0.6521.71±1.10 | 24.86±0.8824.26 ±0.92 | 26.61 ±0.9826.43±1.11 | 29.83±1.0127.93±1.85 |
Claims (4)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN200710036741A CN101007114B (zh) | 2007-01-23 | 2007-01-23 | 一种肿瘤患者辅助用药品或保健品及其制备方法 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN200710036741A CN101007114B (zh) | 2007-01-23 | 2007-01-23 | 一种肿瘤患者辅助用药品或保健品及其制备方法 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN101007114A true CN101007114A (zh) | 2007-08-01 |
CN101007114B CN101007114B (zh) | 2010-05-19 |
Family
ID=38695925
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN200710036741A Expired - Fee Related CN101007114B (zh) | 2007-01-23 | 2007-01-23 | 一种肿瘤患者辅助用药品或保健品及其制备方法 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN101007114B (zh) |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN114869987A (zh) * | 2022-05-16 | 2022-08-09 | 西北工业大学 | 一种用于预防和治疗肝癌的中药组合物 |
Family Cites Families (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN100400075C (zh) * | 2005-02-02 | 2008-07-09 | 冯上舒 | 一种补气养血药物组合物及其制备方法 |
-
2007
- 2007-01-23 CN CN200710036741A patent/CN101007114B/zh not_active Expired - Fee Related
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN114869987A (zh) * | 2022-05-16 | 2022-08-09 | 西北工业大学 | 一种用于预防和治疗肝癌的中药组合物 |
Also Published As
Publication number | Publication date |
---|---|
CN101007114B (zh) | 2010-05-19 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN102526474B (zh) | 一种治疗神经衰弱的中药组合物 | |
CN101632819B (zh) | 一种对抗肺癌化疗后骨髓抑制的制剂 | |
CN101530597B (zh) | 一种治疗乳房纤维腺瘤和乳腺增生病的药物 | |
CN100490789C (zh) | 一种治疗癌症的中药肠溶胶囊剂的用途 | |
CN103007206A (zh) | 一种治疗慢性萎缩性胃炎的口服液 | |
CN101711848B (zh) | 一种辅助治疗肿瘤的中药组合物 | |
CN102579803B (zh) | 一种治疗化疗后白细胞减少症的药物及其制备方法 | |
CN102861193B (zh) | 一种治疗胃癌的中药组合物 | |
CN100372558C (zh) | 一种治疗肿瘤放、化疗后白细胞减少的药物 | |
CN103432412B (zh) | 一种治疗乳腺增生的药物及其制备方法 | |
CN105213993A (zh) | 一种改善肠癌恶病质的中药组合物及其制备方法 | |
CN1225258C (zh) | 一种治疗胰腺癌的中药复方制剂 | |
CN101007114B (zh) | 一种肿瘤患者辅助用药品或保健品及其制备方法 | |
CN104524163B (zh) | 一种治疗慢性支气管炎合并肺癌的中药组合物及制备方法 | |
CN103990009A (zh) | 一种健脾泄浊法治疗ⅱ型糖尿病中药 | |
CN102743579A (zh) | 一种益气补血中药丸及其制备工艺 | |
CN106581299B (zh) | 一种改善中老年肾气虚证的中药组合物及其应用 | |
CN105213736A (zh) | 一种减肥的中药组合物及其用途 | |
CN101675961B (zh) | 一种治疗乳腺癌的药物制剂及其制备方法 | |
CN104306847A (zh) | 一种六味补气胶囊及其制备工艺 | |
CN104622995A (zh) | 一种治疗慢性浅表性胃炎的药物组合物及其制备方法 | |
CN101406625B (zh) | 一种治疗癌症的中药组合物及其制备方法和用途 | |
CN101108210B (zh) | 一种治疗颈椎病的药物 | |
CN105434533A (zh) | 一种治疗肝癌的中药组合物 | |
CN105456729A (zh) | 一种治疗化疗、放疗引起的白细胞减少的药物组合物 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
C14 | Grant of patent or utility model | ||
GR01 | Patent grant | ||
ASS | Succession or assignment of patent right |
Owner name: SHANGHAI FANGXIN TECHNOLOGY INSTITUTE Owner name: SHANGHAI FANGXIN HEALTH TECHNOLOGY CO., LTD. Free format text: FORMER OWNER: SHANGHAI FANGXIN TECHNOLOGY INSTITUTE Effective date: 20101216 |
|
C41 | Transfer of patent application or patent right or utility model | ||
COR | Change of bibliographic data |
Free format text: CORRECT: ADDRESS; FROM: 200032 ROOM 888, NO. 1755, XIETU ROAD, SHANGHAI TO: 200032 ROOM C, 13/F, NO. 69, YIXUEYUAN ROAD, XUHUI DISTRICT, SHANGHAI |
|
TR01 | Transfer of patent right |
Effective date of registration: 20101216 Address after: 200032 room 13, building 69, road, Xuhui District Medical College, Shanghai, Co-patentee after: SHANGHAI FANGXIN TECHNOLOGY INSTITUTE Patentee after: SHANGHAI FANGXIN HEALTH TECHNOLOGY DEVELOPMENT Co.,Ltd. Address before: 200032 Shanghai Xietu Road No. 1755 room 888 Patentee before: Shanghai Fangxin Technology Institute |
|
C41 | Transfer of patent application or patent right or utility model | ||
C56 | Change in the name or address of the patentee | ||
CP03 | Change of name, title or address |
Address after: 201203 Shanghai Zhangjiang hi tech Park Cailun Road, room 716 No. 780 Patentee after: SHANGHAI FANGXIN HEALTH TECHNOLOGY DEVELOPMENT Co.,Ltd. Patentee after: SHANGHAI FANGXIN TECHNOLOGY INSTITUTE Address before: 200032 room 13, building 69, road, Xuhui District Medical College, Shanghai, Patentee before: SHANGHAI FANGXIN HEALTH TECHNOLOGY DEVELOPMENT Co.,Ltd. Patentee before: Shanghai Fangxin Technology Institute |
|
TR01 | Transfer of patent right |
Effective date of registration: 20160216 Address after: 201203 Shanghai Zhangjiang hi tech Park Cailun Road, room 716 No. 780 Patentee after: SHANGHAI FANGXIN HEALTH TECHNOLOGY DEVELOPMENT Co.,Ltd. Address before: 201203 Shanghai Zhangjiang hi tech Park Cailun Road, room 716 No. 780 Patentee before: SHANGHAI FANGXIN HEALTH TECHNOLOGY DEVELOPMENT Co.,Ltd. Patentee before: Shanghai Fangxin Technology Institute |
|
TR01 | Transfer of patent right |
Effective date of registration: 20210813 Address after: 200032 Block C, 13th floor, No. 69, Medical College Road, Xuhui District, Shanghai Patentee after: SHANGHAI CIJI PHARMACEUTICAL Co.,Ltd. Address before: Room 716, 780 Cailun Road, Zhangjiang hi tech park, Shanghai 201203 Patentee before: SHANGHAI FANGXIN HEALTH TECHNOLOGY DEVELOPMENT Co.,Ltd. |
|
TR01 | Transfer of patent right | ||
CF01 | Termination of patent right due to non-payment of annual fee | ||
CF01 | Termination of patent right due to non-payment of annual fee |
Granted publication date: 20100519 |